China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study of Tofacitinib in the Treatment of Prurigo Nodularis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133127
Registration Time: 2026/09/22
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of the Army Medical University of the Chinese People’s Liberation Army
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344771
Published by HT Digital Content Services with permission from Health Daily Digest....